Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Post-COVID, many patients experience skin issues like hair loss and herpes reactivation, especially in middle-aged women.

Ayurvedic Rasayan formulations like Chyawanprash may help manage post-COVID symptoms by boosting immunity.

Pharmacist-led care significantly improved post-COVID symptoms.

An elderly woman developed severe skin discoloration after homeopathic knee injections, but the exact cause is unclear.

Isotretinoin effectively improved severe pityriasis rubra pilaris with complications.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Combining standard treatment with exogenous cholinesterases can improve outcomes in severe organophosphate poisoning.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Combining methotrexate and corticosteroids can effectively regrow hair in severe alopecia areata.

In the late 19th century, Jagiellonian University in Krakow was a hub for medical innovations in surgery, diagnostics, and cardiology.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Kampo medicine can help treat general fatigue from long COVID.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Baricitinib is an effective treatment for severe alopecia areata.

New treatments for severe alopecia areata show promise but lack standard approval.

New medications could improve treatment for severe alopecia areata in Australia.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

CTP-543 is generally safe for treating alopecia areata.

Researchers found four genes that could help diagnose severe alopecia areata early.

Infectious cerebral vasculitis can be a severe complication of meningoencephalitis, regardless of the pathogen.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Therapy lowers IgM levels in dogs with severe dermatitis but not in mild cases.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Mesalazine showed limited effectiveness in treating children with severe alopecia areata.